Ruyi He
Chief Tech/Sci/R&D Officer chez REMEGEN CO., LTD.
Fortune : 6 M $ au 31/03/2024
Provenance du réseau au premier degré de Ruyi He
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Pharmaceuticals: Major | 15 | |
China Medical University
7
| College/University | Other Consumer Services | 7 |
Genuine Biotech Ltd.
 Genuine Biotech Ltd. BiotechnologyHealth Technology Genuine Biotech Ltd. engages in the development, manufacturing, and commercialization of innovative drugs for the treatment of viral, oncological, and cerebrovascular diseases. The company was founded in 2012 and is headquartered in Pingdingshan, China.
7
| Private Company | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ruyi He via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Pharmaceuticals: Major | President Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| University of Alberta | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree | |
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Graduate Degree Graduate Degree | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Sales & Marketing | |
| Tsinghua University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| Soochow University | College/University | Graduate Degree Graduate Degree | |
| Shanghai Jiao Tong University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| China Europe International Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Chinese University of Hong Kong | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Zhejiang University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Chinese Academy of Sciences | College/University | Graduate Degree Doctorate Degree | |
| Shandong University | College/University | Undergraduate Degree Graduate Degree | |
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Biotechnology | Director/Board Member | |
Goldman Sachs (Asia) LLC
 Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments. | Investment Banks/Brokers | Analyst-Equity Director/Board Member | |
| Beijing Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Harbin University of Commerce | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Arkansas for Medical Sciences | College/University | Corporate Officer/Principal | |
| Chinese Pharmaceutical Association | Director/Board Member Director/Board Member | ||
| Fourth Military Medical University | College/University | Graduate Degree | |
| Sun Yat-Sen University | College/University | Corporate Officer/Principal Graduate Degree | |
| Yantai University | College/University | Undergraduate Degree Undergraduate Degree | |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
| HANGZHOU TIGERMED CONSULTING CO., LTD | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| SHANGHAI HIUV NEW MATERIALS CO.,LTD | Containers/Packaging | Director/Board Member | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| HOSPITAL CORPORATION OF CHINA LIMITED | Hospital/Nursing Management | Chief Executive Officer Chief Executive Officer | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Founder Director/Board Member President Chief Executive Officer Director/Board Member Sales & Marketing President | |
SWCS Corporate Services Group (Hong Kong) Ltd.
 SWCS Corporate Services Group (Hong Kong) Ltd. Miscellaneous Commercial ServicesCommercial Services SWCS Corporate Services Group Hong Kong Ltd. provides accounting, payroll, and management consulting services. The private company is based in Hong Kong, Hong Kong. Wai Fung Ngai has been the CEO of the Chinese company since 2011. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Biotechnology | Director/Board Member | |
| CBC Group Co., Ltd. | Chief Executive Officer | ||
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| C-Bridge Capital Investment Management Ltd. | Chief Executive Officer | ||
| Yantai Rongchang Pharmaceutical Co. Ltd. | Corporate Officer/Principal Founder Corporate Officer/Principal | ||
| Remegen Biosciences, Inc. | Director/Board Member Director/Board Member | ||
| The Hong Kong Chartered Governance Institute | Corporate Officer/Principal Corporate Officer/Principal | ||
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Pharmaceuticals: Generic | Corporate Officer/Principal Sales & Marketing | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Graduate Degree | |
Fidelidade Companhia de Seguros SA
 Fidelidade Companhia de Seguros SA Investment ManagersFinance Fidelidade Companhia de Seguros SA (Fidelidade) is the Portuguese insurance subsidiary of LongRun Portugal SGPS SA, ultimately held by Fosun International Holdings Ltd. in the Virgin Islands. Formerly known as Companhia de Seguros Fidelidade Mundial SA, the firm’s heritage date to 1808. In 2012 they merged with Imperio Bonança and changed their name to Fidelidade Companhia de Seguros SA. Fidelidade is headquartered in Lisbon and provides life and non-life insurance tofamilies and businesses in Portugal. | Investment Managers | Chairman |
Statistiques
Internationale
| Chine | 25 |
| Etats-Unis | 9 |
| Hong Kong | 7 |
| Canada | 4 |
| Îles Cayman | 4 |
Sectorielle
| Consumer Services | 23 |
| Health Technology | 15 |
| Finance | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 217 |
| Corporate Officer/Principal | 102 |
| Independent Dir/Board Member | 73 |
| Undergraduate Degree | 54 |
| Doctorate Degree | 35 |
Relations les plus connectées
| Insiders | |
|---|---|
| Chia Hung Yang | 31 |
| Lan Kang | 22 |
| Wei Fu | 21 |
| Pamela Klein | 19 |
| Shuai Chen | 19 |
| Lorne Babiuk | 18 |
| Richard Yeh | 18 |
| Chun Kwok Au | 14 |
| Jingwu Zhang Zang | 13 |
| Hui Xin Liang | 13 |
| Shao Jing Tong | 12 |
| Rong Shao | 12 |
| Ke Jian Zhang | 12 |
| Rajkumar Kannan | 11 |
| Pak Yu Tam | 11 |
